Eileen Scully, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Investigator

Email:

escully1@jhmi.edu

Dr. Eileen Scully is an assistant professor of medicine at the Johns Hopkins University School of Medicine. 

She received her B.S. from the University of Notre Dame. She earned her Ph.D. and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital.

  • Protocol Chair, ACTG A5366
  • Investigator, Women's Health Inter-Network Scientific Committee (Dec 2017-Nov 2019)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

IMPAACT 2034 - Phase I Study of the Pharmacokinetics,...

This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...

Read More

The Pharmacokinetics, Safety and Acceptability of New...

PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...

Read More

A5300B/I2003B/PHOENIX, Protecting Households On Exposure to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

Read More